Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Y. Barthe · SciRah

Researcher profile · Semantic Scholar

Y. Barthe

Share profile

Y. Barthe — researcher profile on SciRah

h-index: 8
Works: 15
Citations: 1,102

Most-cited papers

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.
C. Hézode, H. Fontaine, C. Dorival, D. Larrey +34 more
2013Journal of Hepatology454 citations
Semantic Scholar
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.
C. Hézode, H. Fontaine, C. Dorival, F. Zoulim +36 more
2014Gastroenterology265 citations Open access
Semantic Scholar
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-
M. Bourlière, P. Rabiéga, N. Ganne-Carrié, L. Serfaty +23 more
2017The Lancet Gastroenterology and Hepatology103 citations Open access
Semantic Scholar
Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B‐cell non‐Hodgkin lymphomas, ANRS HC‐13 lympho‐C study
J. Michot, D. Canioni, H. Driss, L. Alric +23 more
2015American journal of hematology/oncology99 citations
Semantic Scholar
8 SAFETY OF TELAPREVIR OR BOCEPREVIR IN COMBINATION WITH PEGINTERFERON ALFA/RIBAVIRIN, IN CIRRHOTIC NON RESPONDERS. FIRST RESULTS OF THE FRENCH EARLY ACCESS PROGRAM (ANRS CO20-CUPIC)
C. Hézode, C. Dorival, F. Zoulim, T. Poynard +14 more
201290 citations
Semantic Scholar
60 SVR12 RATES AND SAFETY OF TRIPLE THERAPY INCLUDING TELAPREVIR OR BOCEPREVIR IN 221 CIRRHOTIC NON RESPONDERS TREATED IN THE FRENCH EARLY ACCESS PROGRAM (ANRS CO20-CUPIC)
H. Fontaine, C. Hézode, C. Dorival, D. Larrey +17 more
201337 citations
Semantic Scholar
Coronary heart disease is associated with a worse clinical outcome of hand osteoarthritis: a cross-sectional and longitudinal study
A. Courties, J. Sellam, E. Maheu, C. Cadet +3 more
2017RMD Open32 citations Open access
Semantic Scholar
Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study.
P. Miailhes, M. Maynard-Muet, F. Lebossé, F. Carrat +9 more
2014Journal of Hepatology16 citations
Semantic Scholar
Plasma apolipoprotein H limits HCV replication and associates with response to NS3 protease inhibitors‐based therapy
Philippe Sultanik, V. Mallet, S. Lagaye, A. Casrouge +13 more
2015Liver international (Print)5 citations
Semantic Scholar
Reply to: From the CUPIC study: great times are not coming (?).
F. Carrat, Y. Barthe, C. Hézode, H. Fontaine +1 more
2014Journal of Hepatology2 citations Open access
Semantic Scholar
Cardiometabolic disturbances and hand osteoarthritis: A cross-sectional and longitudinal study
A. Courties, J. Sellam, E. Maheu, C. Cadet +3 more
20150 citations Open access
Semantic Scholar
P0768 : Late mortality in treatment-experienced cirrhotic patients treated with triple therapy including boceprevir or telaprevir in a real-life cohort - ANRS Co 20 cupic
J. Bronowicki, H. Fontaine, C. Dufour, F. Zoulim +34 more
20150 citations
Semantic Scholar
Reply to: "From the CUPIC study: great times are not coming(?)".
C. Hézode, H. Fontaine, Y. Barthe, F. Carrat +1 more
2014Journal of Hepatology0 citations Open access
Semantic Scholar
What happens to Kellgren-Lawrence grade 1 joints in hand osteoarthritis (OA) after 2.6 years ? “OA or not OA that is the question ?” - Data from the SEKOIA trial
E. Maheu, C. Cadet, F. Carrat, Y. Barthe +1 more
20140 citations Open access
Semantic Scholar
1429 BASELINE APOLIPOPROTEIN H (ApoH) IS A PREDICTOR OF EARLY VIROLOGIC RESPONSE TO TRIPLE THERAPY (ANRS CO20-CUPIC)
Philippe Sultanik, V. Mallet, C. Dorival-Mouly, Y. Barthe +12 more
20130 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Carrat×15
Invite
F. Carrat — researcher profile on SciRah
C. Hézode×10
Invite
C. Hézode — researcher profile on SciRah
J. Bronowicki×10
Invite
J. Bronowicki — researcher profile on SciRah
H. Fontaine×9
Invite
H. Fontaine — researcher profile on SciRah

×9

Invite

S. Pol — researcher profile on SciRah

Invite

F. Zoulim — researcher profile on SciRah

Invite

L. Alric — researcher profile on SciRah

M. Bourlière×6

Invite

M. Bourlière — researcher profile on SciRah

Invite

G. Riachi — researcher profile on SciRah

Invite

P. Cacoub — researcher profile on SciRah

Invite

C. Dorival — researcher profile on SciRah

Invite

D. Larrey — researcher profile on SciRah